Expression and use of anti-CD20 Antibodies
US7744877B2 · kind B2 · utility
18Cited by
32References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 11, 2002 |
| Grant date | Jun 29, 2010 |
| Priority date | — |
| Expiry date | Apr 18, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/867
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are methods of depleting peripheral blood B cells in a human host comprising administering to the host an immunologically active anti-CD20 antibody in an amount effective to deplete peripheral blood B cells in the host.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.